Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	beta-catenin binding	AR EP300 KANK1	2.24e-04	120	20	3	GO:0008013
GeneOntologyMolecularFunction	RNA polymerase II general transcription initiation factor binding	AR HNRNPU	3.30e-04	27	20	2	GO:0001091
GeneOntologyMolecularFunction	nuclear androgen receptor binding	AR EP300	4.94e-04	33	20	2	GO:0050681
GeneOntologyMolecularFunction	transition metal ion binding	SEC24C TET2 TCHHL1 AR EP300 SEC24B	8.27e-04	1189	20	6	GO:0046914
GeneOntologyMolecularFunction	transcription coactivator binding	AR EP300	1.32e-03	54	20	2	GO:0001223
GeneOntologyMolecularFunction	zinc ion binding	SEC24C TET2 AR EP300 SEC24B	1.55e-03	891	20	5	GO:0008270
GeneOntologyMolecularFunction	pre-mRNA binding	EP300 HNRNPU	1.85e-03	64	20	2	GO:0036002
GeneOntologyMolecularFunction	general transcription initiation factor binding	AR HNRNPU	1.85e-03	64	20	2	GO:0140296
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	AR HNRNPU	1.97e-03	66	20	2	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	AR HNRNPU	1.97e-03	66	20	2	GO:0001098
GeneOntologyMolecularFunction	double-stranded RNA binding	TLR8 HNRNPU	2.73e-03	78	20	2	GO:0003725
GeneOntologyMolecularFunction	promoter-specific chromatin binding	EP300 HNRNPU	3.09e-03	83	20	2	GO:1990841
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	AR EP300 YTHDF3 HNRNPU ATN1	4.89e-03	1160	20	5	GO:0030674
GeneOntologyMolecularFunction	single-stranded RNA binding	TLR8 HNRNPU	5.45e-03	111	20	2	GO:0003727
GeneOntologyMolecularFunction	chromatin binding	SATB1 AR EP300 HNRNPU	5.62e-03	739	20	4	GO:0003682
GeneOntologyMolecularFunction	transcription factor binding	SATB1 AR EP300 HNRNPU	6.00e-03	753	20	4	GO:0008134
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SATB1 AR FUBP1 EP300 HNRNPU	6.57e-03	1244	20	5	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SATB1 AR FUBP1 EP300 HNRNPU	7.19e-03	1271	20	5	GO:0000987
GeneOntologyMolecularFunction	single-stranded DNA binding	FUBP1 HNRNPU	7.85e-03	134	20	2	GO:0003697
GeneOntologyMolecularFunction	SNARE binding	SEC24C SEC24B	8.07e-03	136	20	2	GO:0000149
GeneOntologyMolecularFunction	transcription coregulator binding	AR EP300	8.54e-03	140	20	2	GO:0001221
GeneOntologyMolecularFunction	molecular adaptor activity	AR EP300 YTHDF3 HNRNPU ATN1	9.41e-03	1356	20	5	GO:0060090
GeneOntologyMolecularFunction	chromatin DNA binding	EP300 HNRNPU	1.20e-02	167	20	2	GO:0031490
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SATB1 AR FUBP1 EP300 HNRNPU	1.27e-02	1459	20	5	GO:0000977
GeneOntologyMolecularFunction	nuclear receptor binding	AR EP300	1.48e-02	187	20	2	GO:0016922
GeneOntologyMolecularFunction	transcription coregulator activity	EP300 HNRNPU ATN1	1.77e-02	562	20	3	GO:0003712
GeneOntologyMolecularFunction	ribonucleoprotein complex binding	YTHDF3 HNRNPU	1.78e-02	206	20	2	GO:0043021
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	SATB1 AR EP300	1.94e-02	582	20	3	GO:0140297
GeneOntologyMolecularFunction	transcription corepressor activity	HNRNPU ATN1	2.17e-02	229	20	2	GO:0003714
GeneOntologyCellularComponent	COPII vesicle coat	SEC24C SEC24B	9.32e-05	16	19	2	GO:0030127
GeneOntologyCellularComponent	nuclear matrix	SATB1 HNRNPU ATN1	2.63e-04	140	19	3	GO:0016363
GeneOntologyCellularComponent	nuclear periphery	SATB1 HNRNPU ATN1	4.73e-04	171	19	3	GO:0034399
GeneOntologyCellularComponent	endoplasmic reticulum exit site	SEC24C SEC24B	6.59e-04	42	19	2	GO:0070971
GeneOntologyCellularComponent	ER to Golgi transport vesicle membrane	SEC24C SEC24B	1.53e-03	64	19	2	GO:0012507
GeneOntologyCellularComponent	vesicle coat	SEC24C SEC24B	1.67e-03	67	19	2	GO:0030120
GeneOntologyCellularComponent	cytoplasmic ribonucleoprotein granule	TNRC6B YTHDF3 HNRNPU	1.75e-03	269	19	3	GO:0036464
GeneOntologyCellularComponent	ribonucleoprotein granule	TNRC6B YTHDF3 HNRNPU	2.11e-03	287	19	3	GO:0035770
GeneOntologyCellularComponent	P-body	TNRC6B YTHDF3	3.82e-03	102	19	2	GO:0000932
GeneOntologyCellularComponent	membrane coat	SEC24C SEC24B	4.12e-03	106	19	2	GO:0030117
GeneOntologyCellularComponent	coated membrane	SEC24C SEC24B	4.12e-03	106	19	2	GO:0048475
GeneOntologyCellularComponent	COPII-coated ER to Golgi transport vesicle	SEC24C SEC24B	4.43e-03	110	19	2	GO:0030134
GeneOntologyCellularComponent	nuclear speck	PNISR AR HNRNPU	6.60e-03	431	19	3	GO:0016607
GeneOntologyCellularComponent	nuclear body	SATB1 PNISR AR HNRNPU	7.98e-03	903	19	4	GO:0016604
Domain	Sec23/24_helical_dom	SEC24C SEC24B	1.47e-05	6	19	2	IPR006900
Domain	Sec23/24_trunk_dom	SEC24C SEC24B	1.47e-05	6	19	2	IPR006896
Domain	Znf_Sec23_Sec24	SEC24C SEC24B	1.47e-05	6	19	2	IPR006895
Domain	Sec23_24_beta_S	SEC24C SEC24B	1.47e-05	6	19	2	IPR012990
Domain	zf-Sec23_Sec24	SEC24C SEC24B	1.47e-05	6	19	2	PF04810
Domain	Sec23_trunk	SEC24C SEC24B	1.47e-05	6	19	2	PF04811
Domain	Sec23_helical	SEC24C SEC24B	1.47e-05	6	19	2	PF04815
Domain	Sec23_BS	SEC24C SEC24B	1.47e-05	6	19	2	PF08033
Domain	Gelsolin	SEC24C SEC24B	8.86e-05	14	19	2	PF00626
Domain	Gelsolin-like_dom	SEC24C SEC24B	8.86e-05	14	19	2	IPR007123
Domain	-	SEC24C SEC24B	2.67e-04	24	19	2	3.40.20.10
Domain	ADF-H/Gelsolin-like_dom	SEC24C SEC24B	2.67e-04	24	19	2	IPR029006
Domain	-	SEC24C SEC24B	2.54e-03	74	19	2	3.40.50.410
Domain	VWF_A	SEC24C SEC24B	4.48e-03	99	19	2	IPR002035
Domain	Ubiquitin-rel_dom	HERPUD2 PLCE1	1.48e-02	184	19	2	IPR029071
Pathway	KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION	SEC24C SEC24B	5.15e-05	12	13	2	M47770
Pathway	REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES	SEC24C TLR8 SEC24B	1.87e-04	126	13	3	M45009
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	SEC24C SEC24B	2.33e-04	25	13	2	MM15713
Pathway	REACTOME_TGFBR3_EXPRESSION	TNRC6B EP300	2.93e-04	28	13	2	M48253
Pathway	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	TNRC6B EP300 KANK1	3.06e-04	149	13	3	M27888
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	SEC24C SEC24B	3.14e-04	29	13	2	M1062
Pathway	REACTOME_CARGO_CONCENTRATION_IN_THE_ER	SEC24C SEC24B	4.08e-04	33	13	2	M27591
Pathway	REACTOME_SUMOYLATION	SATB1 AR EP300	4.43e-04	169	13	3	MM14919
Pathway	REACTOME_CARGO_CONCENTRATION_IN_THE_ER	SEC24C SEC24B	4.86e-04	36	13	2	MM15300
Pathway	REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX	TNRC6B EP300	5.13e-04	37	13	2	M29790
Pathway	REACTOME_SUMOYLATION	SATB1 AR EP300	6.14e-04	189	13	3	M27214
Pathway	REACTOME_SARS_COV_INFECTIONS	SEC24C TLR8 EP300 SEC24B	6.92e-04	471	13	4	M39009
Pathway	PID_HNF3A_PATHWAY	AR EP300	7.27e-04	44	13	2	M285
Pathway	REACTOME_SARS_COV_2_HOST_INTERACTIONS	SEC24C TLR8 SEC24B	7.67e-04	204	13	3	M45011
Pathway	REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING	TNRC6B EP300	8.29e-04	47	13	2	M29777
Pathway	PID_HES_HEY_PATHWAY	AR EP300	8.65e-04	48	13	2	M288
Pathway	REACTOME_SIGNALING_BY_TGFBR3	TNRC6B EP300	9.01e-04	49	13	2	M48250
Pathway	REACTOME_ESR_MEDIATED_SIGNALING	TNRC6B EP300 KANK1	9.55e-04	220	13	3	M27794
Pathway	PID_AR_TF_PATHWAY	AR EP300	1.05e-03	53	13	2	M151
Pathway	REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	SEC24C SEC24B	1.13e-03	55	13	2	M27001
Pathway	WP_SIDS_SUSCEPTIBILITY_PATHWAYS	AR EP300	1.30e-03	59	13	2	MM15838
Pathway	REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT	SEC24C SEC24B	1.78e-03	69	13	2	M27113
Pathway	WP_KIT_RECEPTOR_SIGNALING_PATHWAY	EP300 PLCE1	1.88e-03	71	13	2	MM15947
Pathway	WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING	SEC24C SEC24B	1.88e-03	71	13	2	M39395
Pathway	WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3	TLR8 PLCE1	2.10e-03	75	13	2	M39568
Pathway	REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS	TNRC6B EP300 KANK1	2.24e-03	296	13	3	M27869
Pathway	REACTOME_SARS_COV_2_INFECTION	SEC24C TLR8 SEC24B	2.31e-03	299	13	3	M41727
Pathway	WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY	SATB1 EP300 HNRNPU	2.35e-03	301	13	3	MM15983
Pathway	PID_BETA_CATENIN_NUC_PATHWAY	AR EP300	2.38e-03	80	13	2	M223
Pathway	PID_SMAD2_3NUCLEAR_PATHWAY	AR EP300	2.50e-03	82	13	2	M2
Pathway	REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT	SEC24C SEC24B	2.56e-03	83	13	2	MM14819
Pathway	KEGG_PROSTATE_CANCER	AR EP300	2.94e-03	89	13	2	M13191
Pathway	WP_ANDROGEN_RECEPTOR_SIGNALING	AR EP300	3.07e-03	91	13	2	M39700
Pathway	REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION	TNRC6B EP300	3.41e-03	96	13	2	M27792
Pathway	WP_IL6_SIGNALING_PATHWAY	AR EP300	3.69e-03	100	13	2	MM15826
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	SATB1 TNRC6B FUBP1 YTHDF3 HNRNPU SEC24B	1.39e-07	444	20	6	34795231
Pubmed	Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes.	EP300 HNRNPU	3.14e-07	2	20	2	11909954
Pubmed	TET2 binds the androgen receptor and loss is associated with prostate cancer.	TET2 AR	3.14e-07	2	20	2	27819678
Pubmed	Human transcription factor protein interaction networks.	SATB1 TET2 TNRC6B FUBP1 EP300 YTHDF3 SEC24B ATN1	6.45e-07	1429	20	8	35140242
Pubmed	SATB1 makes a complex with p300 and represses gp91(phox) promoter activity.	SATB1 EP300	9.42e-07	3	20	2	14605447
Pubmed	Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.	AR EP300	9.42e-07	3	20	2	23172223
Pubmed	Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction.	AR EP300	9.42e-07	3	20	2	15060161
Pubmed	Interaction network of human early embryonic transcription factors.	SATB1 TET2 EP300 YTHDF3 ATN1	1.39e-06	351	20	5	38297188
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TET2 TNRC6B EP300 ATN1	1.61e-06	152	20	4	38360978
Pubmed	The role of the C-terminal domain of PCSK9 and SEC24 isoforms in PCSK9 secretion.	SEC24C SEC24B	1.88e-06	4	20	2	32058034
Pubmed	p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.	AR EP300	1.88e-06	4	20	2	24480624
Pubmed	Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes.	AR EP300	1.88e-06	4	20	2	32668201
Pubmed	Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling.	AR EP300	1.88e-06	4	20	2	20448036
Pubmed	Functional architecture of atrophins.	EP300 ATN1	1.88e-06	4	20	2	17150957
Pubmed	TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.	TET2 AR	1.88e-06	4	20	2	26404510
Pubmed	p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation.	AR EP300	1.88e-06	4	20	2	10779504
Pubmed	Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.	AR EP300	3.14e-06	5	20	2	18487222
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	SEC24C TNRC6B YTHDF3 KANK1 HNRNPU SEC24B ATN1	3.85e-06	1247	20	7	27684187
Pubmed	Sec24 proteins and sorting at the endoplasmic reticulum.	SEC24C SEC24B	4.71e-06	6	20	2	10075675
Pubmed	JS-K, a nitric oxide pro-drug, regulates growth and apoptosis through the ubiquitin-proteasome pathway in prostate cancer cells.	AR EP300	4.71e-06	6	20	2	28549433
Pubmed	A family of mammalian proteins homologous to yeast Sec24p.	SEC24C SEC24B	4.71e-06	6	20	2	10329445
Pubmed	A novel long intergenic noncoding RNA indispensable for the cleavage of mouse two-cell embryos.	FUBP1 HNRNPU	4.71e-06	6	20	2	27496889
Pubmed	Polyglutamine tracts regulate beclin 1-dependent autophagy.	AR ATN1	4.71e-06	6	20	2	28445460
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TNRC6B FUBP1 EP300 YTHDF3 ATN1	5.05e-06	457	20	5	32344865
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	TNRC6B UCK2 FUBP1 YTHDF3 HNRNPU	5.32e-06	462	20	5	31138677
Pubmed	Selective export of human GPI-anchored proteins from the endoplasmic reticulum.	SEC24C SEC24B	6.59e-06	7	20	2	20427317
Pubmed	Comparison of the number of triplets in SCA1, MJD/SCA3, HD, SBMA, DRPLA, MD, FRAXA and FRDA genes in schizophrenic patients and a healthy population.	AR ATN1	6.59e-06	7	20	2	11121205
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	SEC24C TNRC6B YTHDF3 HNRNPU SEC24B	7.37e-06	494	20	5	26831064
Pubmed	Identification of a novel K311 ubiquitination site critical for androgen receptor transcriptional activity.	AR EP300	8.78e-06	8	20	2	27903893
Pubmed	Quantitative Mass Spectrometry Identifies Novel Host Binding Partners for Pathogenic Escherichia coli Type III Secretion System Effectors.	EP300 SEC24B	8.78e-06	8	20	2	27018634
Pubmed	Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract.	AR ATN1	1.13e-05	9	20	2	9535906
Pubmed	The transport signal on Sec22 for packaging into COPII-coated vesicles is a conformational epitope.	SEC24C SEC24B	1.41e-05	10	20	2	17499046
Pubmed	Structural basis of cargo membrane protein discrimination by the human COPII coat machinery.	SEC24C SEC24B	1.41e-05	10	20	2	18843296
Pubmed	Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.	SEC24C UCK2 EP300 SEC24B	1.70e-05	276	20	4	28319085
Pubmed	Planar cell polarity defects and defective Vangl2 trafficking in mutants for the COPII gene Sec24b.	SEC24C SEC24B	2.07e-05	12	20	2	20215345
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	SEC24C TNRC6B KANK1 SEC24B	3.11e-05	322	20	4	39098523
Pubmed	Inhibition of Glycolysis in Pathogenic TH17 Cells through Targeting a miR -21-Peli1-c-Rel Pathway Prevents Autoimmunity.	TNRC6B FUBP1	3.75e-05	16	20	2	32414810
Pubmed	Dioxin receptor is a ligand-dependent E3 ubiquitin ligase.	AR EP300	5.34e-05	19	20	2	17392787
Pubmed	Association studies of 23 positional/functional candidate genes on chromosome 10 in late-onset Alzheimer's disease.	SEC24C PLCE1	5.34e-05	19	20	2	17373700
Pubmed	The ULK1-FBXW5-SEC23B nexus controls autophagy.	SEC24C SEC24B	5.93e-05	20	20	2	30596474
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SEC24C TNRC6B KANK1 PLCE1	7.72e-05	407	20	4	12693553
Pubmed	Conserved beta-hairpin recognition by the GYF domains of Smy2 and GIGYF2 in mRNA surveillance and vesicular transport complexes.	TNRC6B ATN1	7.89e-05	23	20	2	20696395
Pubmed	The Repeat Expansion Diseases: The dark side of DNA repair.	AR ATN1	7.89e-05	23	20	2	26002199
Pubmed	The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA.	FUBP1 HNRNPU	8.61e-05	24	20	2	24798327
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	SEC24C PNISR EP300 ATN1	9.12e-05	425	20	4	24999758
Pubmed	The COPII cargo adapter SEC24C is essential for neuronal homeostasis.	SEC24C SEC24B	1.01e-04	26	20	2	29939162
Pubmed	Proteomic analysis of FOXP proteins reveals interactions between cortical transcription factors associated with neurodevelopmental disorders.	SATB1 FUBP1	1.18e-04	28	20	2	29365100
Pubmed	Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action.	AR EP300	1.18e-04	28	20	2	24880616
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	SEC24C TCHHL1 EP300 HNRNPU SEC24B ATN1	1.22e-04	1451	20	6	30550785
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	PNISR TNRC6B FUBP1 YTHDF3 SEC24B	1.44e-04	922	20	5	27609421
Pubmed	Tangential Intrahypothalamic Migration of the Mouse Ventral Premamillary Nucleus and Fgf8 Signaling.	SATB1 AR	1.45e-04	31	20	2	34095148
Pubmed	Nuclear receptor TLX prevents retinal dystrophy and recruits the corepressor atrophin1.	PLCE1 ATN1	1.45e-04	31	20	2	16702404
Pubmed	BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs.	SATB1 HNRNPU	1.45e-04	31	20	2	23086144
Pubmed	Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level.	TNRC6B UCK2 HNRNPU	1.46e-04	180	20	3	21139048
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	YTHDF3 SEC24B ATN1	1.90e-04	197	20	3	20811636
Pubmed	The CRL4DCAF6 E3 ligase ubiquitinates CtBP1/2 to induce apoptotic signalling and promote intervertebral disc degeneration.	SATB1 AR EP300	1.96e-04	199	20	3	36688959
Pubmed	An AUTS2-Polycomb complex activates gene expression in the CNS.	EP300 ATN1	2.18e-04	38	20	2	25519132
Pubmed	Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.	AR EP300	2.42e-04	40	20	2	34585037
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	SEC24C TET2 FUBP1 HNRNPU	2.47e-04	551	20	4	34728620
Pubmed	Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.	SEC24C HNRNPU ATN1	2.63e-04	220	20	3	24550385
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	AR FUBP1 EP300	2.63e-04	220	20	3	35785414
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	TNRC6B YTHDF3 HNRNPU	2.84e-04	226	20	3	25900982
Pubmed	Three ways to make a vesicle.	SEC24C SEC24B	2.93e-04	44	20	2	11252894
Pubmed	Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice.	TET2 AR	3.34e-04	47	20	2	32892421
Pubmed	Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor.	SEC24C SEC24B	3.79e-04	50	20	2	27716508
Pubmed	The RNA-binding ubiquitin ligase MKRN1 functions in ribosome-associated quality control of poly(A) translation.	TNRC6B HNRNPU	4.58e-04	55	20	2	31640799
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TET2 AR ATN1	4.68e-04	268	20	3	33640491
Pubmed	Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells.	TNRC6B HNRNPU	4.92e-04	57	20	2	17932509
Pubmed	Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry.	UCK2 HNRNPU	4.92e-04	57	20	2	18781797
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	FUBP1 HNRNPU SEC24B	4.99e-04	274	20	3	34244482
Pubmed	Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.	PNISR FUBP1 HNRNPU	5.48e-04	283	20	3	28533407
Interaction	FXR1 interactions	SEC24C TNRC6B AR FUBP1 EP300 YTHDF3 HNRNPU ATN1	8.67e-08	679	19	8	int:FXR1
Interaction	PML interactions	SATB1 TET2 TNRC6B FUBP1 EP300 YTHDF3 HNRNPU SEC24B	9.81e-07	933	19	8	int:PML
Interaction	SEC23B interactions	SEC24C TNRC6B AR EP300 SEC24B	1.59e-06	222	19	5	int:SEC23B
Interaction	SIAH2 interactions	AR EP300 PLCE1 ATN1	2.44e-06	104	19	4	int:SIAH2
Interaction	EYA4 interactions	TET2 TNRC6B EP300 SEC24B ATN1	2.48e-06	243	19	5	int:EYA4
Interaction	IGF2BP1 interactions	SEC24C FUBP1 EP300 YTHDF3 HNRNPU SEC24B	5.11e-06	508	19	6	int:IGF2BP1
Interaction	CSDE1 interactions	SEC24C TNRC6B EP300 YTHDF3 HNRNPU	5.31e-06	284	19	5	int:CSDE1
Interaction	FUBP3 interactions	TNRC6B AR FUBP1 EP300 YTHDF3	6.60e-06	297	19	5	int:FUBP3
Interaction	SLC39A9 interactions	SEC24C HERPUD2 EP300 SEC24B	7.11e-06	136	19	4	int:SLC39A9
Interaction	SP7 interactions	SATB1 TET2 FUBP1 EP300 ATN1	7.39e-06	304	19	5	int:SP7
Interaction	CDC5L interactions	SEC24C PNISR TET2 AR FUBP1 EP300 HNRNPU	7.77e-06	855	19	7	int:CDC5L
Interaction	BRCA1 interactions	SEC24C TNRC6B AR FUBP1 EP300 YTHDF3 HNRNPU SEC24B	8.69e-06	1249	19	8	int:BRCA1
Interaction	MOV10 interactions	SEC24C PNISR TNRC6B FUBP1 EP300 YTHDF3 KANK1 HNRNPU	1.15e-05	1297	19	8	int:MOV10
Interaction	PATL1 interactions	TNRC6B EP300 YTHDF3 SEC24B	2.01e-05	177	19	4	int:PATL1
Interaction	DDX3X interactions	TET2 AR FUBP1 EP300 YTHDF3 HNRNPU	2.10e-05	651	19	6	int:DDX3X
Interaction	SIN3A interactions	SATB1 TET2 AR FUBP1 EP300	2.17e-05	380	19	5	int:SIN3A
Interaction	CLTC interactions	SEC24C TET2 TNRC6B AR EP300 SEC24B	2.18e-05	655	19	6	int:CLTC
Interaction	PIN1 interactions	AR FUBP1 EP300 HNRNPU ATN1	2.25e-05	383	19	5	int:PIN1
Interaction	ALG13 interactions	TNRC6B EP300 YTHDF3 ATN1	2.29e-05	183	19	4	int:ALG13
Interaction	KLF5 interactions	TET2 AR EP300 YTHDF3	2.94e-05	195	19	4	int:KLF5
Interaction	CNOT4 interactions	TNRC6B EP300 YTHDF3	2.99e-05	65	19	3	int:CNOT4
Interaction	PABPC1 interactions	TET2 TNRC6B AR EP300 YTHDF3 HNRNPU	3.14e-05	699	19	6	int:PABPC1
Interaction	NUP35 interactions	TNRC6B FUBP1 EP300 YTHDF3 ATN1	3.67e-05	424	19	5	int:NUP35
Interaction	RNPS1 interactions	PNISR AR FUBP1 EP300 HNRNPU	3.71e-05	425	19	5	int:RNPS1
Interaction	TLE1 interactions	SATB1 AR FUBP1 ATN1	4.15e-05	213	19	4	int:TLE1
Interaction	AICDA interactions	HERPUD2 EP300 HNRNPU	4.24e-05	73	19	3	int:AICDA
Interaction	GAS5 interactions	EP300 YTHDF3	4.61e-05	11	19	2	int:GAS5
Interaction	RTRAF interactions	AR EP300 YTHDF3 HNRNPU	4.88e-05	222	19	4	int:RTRAF
Interaction	ERG interactions	TET2 AR EP300 HNRNPU	4.96e-05	223	19	4	int:ERG
Interaction	SEC24A interactions	SEC24C TNRC6B EP300 SEC24B	5.05e-05	224	19	4	int:SEC24A
Interaction	SRA1 interactions	SEC24C HNRNPU SEC24B	6.22e-05	83	19	3	int:SRA1
Interaction	B4GALT1 interactions	SEC24C EP300 SEC24B	6.45e-05	84	19	3	int:B4GALT1
Interaction	SEC24B interactions	SEC24C TNRC6B EP300 SEC24B	6.61e-05	240	19	4	int:SEC24B
Interaction	DDX23 interactions	PNISR AR FUBP1 EP300 HNRNPU	6.62e-05	480	19	5	int:DDX23
Interaction	ITGAL interactions	EP300 HNRNPU	7.61e-05	14	19	2	int:ITGAL
Interaction	CDK7 interactions	PNISR AR EP300 YTHDF3 HNRNPU	8.11e-05	501	19	5	int:CDK7
Interaction	DDX6 interactions	TNRC6B FUBP1 EP300 YTHDF3 HNRNPU	8.26e-05	503	19	5	int:DDX6
Interaction	G3BP1 interactions	SEC24C TNRC6B AR EP300 YTHDF3 HNRNPU	8.48e-05	835	19	6	int:G3BP1
Interaction	KAT2B interactions	SATB1 AR EP300 HNRNPU	8.48e-05	256	19	4	int:KAT2B
Interaction	RERE interactions	AR EP300 ATN1	8.74e-05	93	19	3	int:RERE
Interaction	SRY interactions	AR EP300	8.78e-05	15	19	2	int:SRY
Interaction	PSPC1 interactions	TET2 AR EP300 YTHDF3 HNRNPU	9.24e-05	515	19	5	int:PSPC1
Interaction	PIAS3 interactions	SATB1 AR EP300	9.31e-05	95	19	3	int:PIAS3
Interaction	PRRC2B interactions	TNRC6B AR YTHDF3 ATN1	9.70e-05	265	19	4	int:PRRC2B
Interaction	MED23 interactions	PNISR TNRC6B AR EP300	9.84e-05	266	19	4	int:MED23
Interaction	FOXP4 interactions	SATB1 AR FUBP1	1.02e-04	98	19	3	int:FOXP4
Interaction	HDAC2 interactions	SATB1 TET2 AR FUBP1 EP300 HNRNPU	1.03e-04	865	19	6	int:HDAC2
Interaction	PPIL3 interactions	SEC24C AR HNRNPU	1.08e-04	100	19	3	int:PPIL3
Interaction	NPRL3 interactions	SEC24C AR EP300	1.22e-04	104	19	3	int:NPRL3
Interaction	CAND1 interactions	SEC24C TNRC6B AR EP300 HNRNPU SEC24B	1.24e-04	894	19	6	int:CAND1
Interaction	NONO interactions	TET2 AR FUBP1 EP300 HNRNPU	1.25e-04	549	19	5	int:NONO
Interaction	RBM14 interactions	AR FUBP1 EP300 HNRNPU ATN1	1.29e-04	553	19	5	int:RBM14
Interaction	PUM1 interactions	TNRC6B FUBP1 EP300 YTHDF3	1.32e-04	287	19	4	int:PUM1
Interaction	GTF2H1 interactions	AR FUBP1 HNRNPU	1.33e-04	107	19	3	int:GTF2H1
Interaction	CELF1 interactions	TNRC6B FUBP1 YTHDF3 HNRNPU	1.34e-04	288	19	4	int:CELF1
Interaction	TLX3 interactions	SATB1 TET2 AR EP300	1.39e-04	291	19	4	int:TLX3
Interaction	PRMT1 interactions	SEC24C TET2 AR FUBP1 EP300 HNRNPU	1.53e-04	929	19	6	int:PRMT1
Interaction	UPF1 interactions	SEC24C FUBP1 EP300 YTHDF3 HNRNPU	1.63e-04	581	19	5	int:UPF1
Interaction	TBXT interactions	SATB1 EP300 ATN1	1.68e-04	116	19	3	int:TBXT
Interaction	KHSRP interactions	AR FUBP1 EP300 SEC24B	1.73e-04	308	19	4	int:KHSRP
Interaction	TNIP2 interactions	PNISR TNRC6B FUBP1 EP300 YTHDF3 SEC24B	1.75e-04	952	19	6	int:TNIP2
Interaction	ATXN2 interactions	TNRC6B FUBP1 YTHDF3 HNRNPU	1.82e-04	312	19	4	int:ATXN2
Interaction	TRAPPC2L interactions	SEC24C EP300 SEC24B	1.95e-04	122	19	3	int:TRAPPC2L
Interaction	HSF1 interactions	SEC24C FUBP1 EP300 HNRNPU SEC24B	2.03e-04	609	19	5	int:HSF1
Interaction	RUNX1 interactions	AR FUBP1 EP300 HNRNPU	2.10e-04	324	19	4	int:RUNX1
Interaction	AR interactions	TET2 AR FUBP1 EP300 HNRNPU ATN1	2.19e-04	992	19	6	int:AR
Interaction	ZYX interactions	SEC24C TNRC6B EP300 YTHDF3	2.23e-04	329	19	4	int:ZYX
Interaction	R3HDM2 interactions	TNRC6B YTHDF3 SEC24B	2.30e-04	129	19	3	int:R3HDM2
Interaction	PAX9 interactions	SATB1 EP300 ATN1	2.36e-04	130	19	3	int:PAX9
Interaction	CTNNB1 interactions	SEC24C SATB1 AR EP300 HNRNPU SEC24B	2.40e-04	1009	19	6	int:CTNNB1
Interaction	CXXC1 interactions	TET2 EP300 ATN1	2.46e-04	132	19	3	int:CXXC1
Interaction	HNRNPD interactions	SEC24C AR FUBP1 EP300 HNRNPU	2.52e-04	638	19	5	int:HNRNPD
Interaction	TRAPPC5 interactions	SEC24C EP300 SEC24B	2.63e-04	135	19	3	int:TRAPPC5
Interaction	FOXO1 interactions	SATB1 AR EP300 YTHDF3	2.73e-04	347	19	4	int:FOXO1
Interaction	RBM27 interactions	AR FUBP1 EP300	2.75e-04	137	19	3	int:RBM27
Interaction	TNRC6C interactions	TNRC6B YTHDF3 SEC24B	2.81e-04	138	19	3	int:TNRC6C
Interaction	HNRNPUL1 interactions	AR FUBP1 EP300 HNRNPU	2.85e-04	351	19	4	int:HNRNPUL1
Interaction	MDM2 interactions	AR FUBP1 EP300 HNRNPU PLCE1	2.90e-04	658	19	5	int:MDM2
Interaction	PIAS1 interactions	SATB1 AR EP300 HNRNPU	2.91e-04	353	19	4	int:PIAS1
Interaction	BMI1 interactions	TNRC6B AR EP300 YTHDF3 SEC24B	2.92e-04	659	19	5	int:BMI1
Interaction	HDAC7 interactions	AR EP300 HNRNPU	2.99e-04	141	19	3	int:HDAC7
Interaction	TADA3 interactions	AR EP300 ATN1	2.99e-04	141	19	3	int:TADA3
Interaction	SUDS3 interactions	TET2 AR EP300	2.99e-04	141	19	3	int:SUDS3
Interaction	MYH10 interactions	TET2 AR EP300 HNRNPU	3.11e-04	359	19	4	int:MYH10
Interaction	PCBP1 interactions	TNRC6B AR FUBP1 EP300 HNRNPU	3.18e-04	671	19	5	int:PCBP1
Interaction	ZNF148 interactions	SEC24C AR EP300	3.18e-04	144	19	3	int:ZNF148
Interaction	DAZL interactions	TNRC6B FUBP1 YTHDF3	3.25e-04	145	19	3	int:DAZL
Interaction	DCAF7 interactions	SEC24C AR EP300 SEC24B	3.41e-04	368	19	4	int:DCAF7
Interaction	MCM2 interactions	AR FUBP1 EP300 YTHDF3 HNRNPU SEC24B	3.48e-04	1081	19	6	int:MCM2
Interaction	GAPDH interactions	TET2 AR EP300 HNRNPU ATN1	3.52e-04	686	19	5	int:GAPDH
Interaction	RTCB interactions	AR EP300 YTHDF3 HNRNPU	3.66e-04	375	19	4	int:RTCB
Interaction	TLE3 interactions	TET2 AR EP300 ATN1	3.70e-04	376	19	4	int:TLE3
Interaction	YAP1 interactions	TNRC6B AR FUBP1 EP300 HNRNPU ATN1	3.73e-04	1095	19	6	int:YAP1
Interaction	AGO3 interactions	TNRC6B YTHDF3 HNRNPU	3.80e-04	153	19	3	int:AGO3
Interaction	XRN2 interactions	AR FUBP1 EP300 HNRNPU	3.89e-04	381	19	4	int:XRN2
Interaction	HDAC1 interactions	SATB1 TET2 TNRC6B AR EP300 HNRNPU	3.98e-04	1108	19	6	int:HDAC1
Interaction	PHB1 interactions	TNRC6B UCK2 AR EP300 YTHDF3 HNRNPU	4.28e-04	1123	19	6	int:PHB1
Interaction	GLUL interactions	AR EP300 HNRNPU	4.33e-04	160	19	3	int:GLUL
Interaction	ETV5 interactions	AR EP300	4.37e-04	33	19	2	int:ETV5
Interaction	TRERF1 interactions	AR EP300	4.37e-04	33	19	2	int:TRERF1
Cytoband	Ensembl 112 genes in cytogenetic band chr22q13	TNRC6B EP300	8.99e-03	330	20	2	chr22q13
Coexpression	GSE6259_CD4_TCELL_VS_CD8_TCELL_DN	HERPUD2 TET2 TLR8 EP300	1.04e-05	184	20	4	M6739
Coexpression	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	PNISR UCK2 FUBP1 HNRNPU	3.06e-05	242	20	4	M904
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	PNISR UCK2 FUBP1 YTHDF3 SEC24B PLCE1	3.12e-05	856	20	6	M4500
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	SATB1 PNISR FUBP1 YTHDF3 SEC24B	3.62e-05	519	20	5	M3395
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	SATB1 PNISR FUBP1 YTHDF3 SEC24B	4.49e-05	543	20	5	MM997
Coexpression	PYEON_HPV_POSITIVE_TUMORS_UP	PNISR FUBP1 HNRNPU	6.04e-05	101	20	3	M7738
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	HERPUD2 PNISR TET2 TNRC6B KANK1 PDZRN4	1.27e-04	1102	20	6	M2369
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	HERPUD2 PNISR TET2 TNRC6B KANK1 PDZRN4	1.42e-04	1124	20	6	MM1070
Coexpression	GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP	SATB1 TNRC6B UCK2	2.63e-04	166	20	3	M7722
Coexpression	RIZ_ERYTHROID_DIFFERENTIATION_12HR	SATB1 AR	3.43e-04	36	20	2	M4389
Coexpression	RIZ_ERYTHROID_DIFFERENTIATION_12HR	SATB1 AR	3.43e-04	36	20	2	MM513
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	PNISR UCK2 FUBP1 SEC24B	3.81e-04	466	20	4	M13522
Coexpression	GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP	SATB1 PNISR TNRC6B	4.09e-04	193	20	3	M6730
Coexpression	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP	HERPUD2 PNISR TET2	4.15e-04	194	20	3	M7313
Coexpression	GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN	SEC24C AR FUBP1	4.40e-04	198	20	3	M5373
Coexpression	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN	SATB1 UCK2 FUBP1	4.40e-04	198	20	3	M6068
Coexpression	GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP	SATB1 FUBP1 HNRNPU	4.40e-04	198	20	3	M7837
Coexpression	GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN	SATB1 PNISR YTHDF3	4.47e-04	199	20	3	M9418
Coexpression	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN	UCK2 KANK1 ATN1	4.47e-04	199	20	3	M8031
Coexpression	GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN	SATB1 YTHDF3 KANK1	4.47e-04	199	20	3	M7659
Coexpression	GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	SATB1 PNISR TNRC6B	4.47e-04	199	20	3	M4460
Coexpression	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN	SEC24C FUBP1 HNRNPU	4.53e-04	200	20	3	M9950
Coexpression	GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP	SATB1 TNRC6B AR	4.53e-04	200	20	3	M7072
Coexpression	GSE27786_LIN_NEG_VS_CD4_TCELL_DN	HERPUD2 TET2 SEC24B	4.53e-04	200	20	3	M4773
Coexpression	GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN	NKPD1 AR HNRNPU	4.53e-04	200	20	3	M4334
Coexpression	LEE_DIFFERENTIATING_T_LYMPHOCYTE	SATB1 PNISR FUBP1	4.60e-04	201	20	3	M2200
Coexpression	ZHENG_BOUND_BY_FOXP3	HERPUD2 SATB1 TNRC6B TLR8	4.90e-04	498	20	4	M1741
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	PNISR TNRC6B KANK1	5.08e-04	208	20	3	M39233
Coexpression	ZHENG_BOUND_BY_FOXP3	HERPUD2 SATB1 TNRC6B TLR8	5.24e-04	507	20	4	MM1030
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	TET2 KANK1 PLCE1	5.37e-04	212	20	3	M39221
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	PNISR TNRC6B KANK1	6.06e-04	221	20	3	M39222
Coexpression	GENTILE_UV_RESPONSE_CLUSTER_D4	KANK1 SEC24B	7.73e-04	54	20	2	M15468
Coexpression	SESTO_RESPONSE_TO_UV_C2	KANK1 HNRNPU	7.73e-04	54	20	2	M2589
Coexpression	TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING	TET2 TNRC6B FUBP1 ATN1	8.02e-04	568	20	4	MM3824
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	FUBP1 HNRNPU	8.91e-04	58	20	2	M2021
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SATB1 PNISR TNRC6B HNRNPU	1.57e-06	195	20	4	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SATB1 TET2 EP300 YTHDF3	1.60e-06	196	20	4	01cea0bb0b938d0986fd2ddae06597b8af1768ee
ToppCell	normal-na-Lymphocytic_T-T8_naive-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	SATB1 PNISR TNRC6B	7.29e-05	184	20	3	4a81190b36d197736663e6177d3b76c1cb6282d6
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SATB1 PNISR TNRC6B	7.41e-05	185	20	3	fcd95bc074e982fc7b8fd48d2e80038b9ea35ebb
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB1 FUBP1 HNRNPU	7.53e-05	186	20	3	11929e36d8c9b4c4bc2f5e912f139f474f91ab00
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KANK1 PLCE1 PDZRN4	7.53e-05	186	20	3	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TNRC6B KANK1 HNRNPU	7.65e-05	187	20	3	e61c1755531469dd3850c9740474b5ad4e0499c1
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KANK1 PLCE1 PDZRN4	7.89e-05	189	20	3	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB1 PNISR TNRC6B	8.14e-05	191	20	3	4bd9db45e7b5c0d04368e08c8199d390744aa317
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TET2 EP300 YTHDF3	8.79e-05	196	20	3	c2bbb48c4aa979b03cb6f4ce9f351f492977c992
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TET2 EP300 YTHDF3	8.79e-05	196	20	3	64c2abc0087bf2ae547932377f3662e3be1cc63e
ToppCell	moderate-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SATB1 PNISR TNRC6B	8.79e-05	196	20	3	9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SATB1 PNISR TNRC6B	8.92e-05	197	20	3	836dd8110d5689f944ad1d301def38c32278b5b5
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 UCK2 HNRNPU	8.92e-05	197	20	3	5bc11aff92da2a0aca8473f997fe7a99f3cae75d
ToppCell	normal\|World / PBMC cell types (v2) per disease, treatment status, and sex	SATB1 PNISR TNRC6B	8.92e-05	197	20	3	232e48864aeb5ad6688352383427fb1771986ddc
ToppCell	PBMC_fresh-frozen\|World / Compartment, severity and other cell annotations on 10x 3' data (130k)	PNISR TNRC6B HNRNPU	9.06e-05	198	20	3	dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a
ToppCell	COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SATB1 PNISR TNRC6B	9.19e-05	199	20	3	885bc902b6e2af0b61e452c4154160cd3f1cf98e
ToppCell	distal-2-Hematologic-Myeloid_Dendritic_Type_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SATB1 TET2 TCHHL1	9.19e-05	199	20	3	86ee039189c75e66b97453c20a34d7fb5a31e51d
ToppCell	lymphoid\|World / Lineage, cell class and subclass	SATB1 PNISR TNRC6B	9.19e-05	199	20	3	bf599721e7109cf9f361e9381544c291920c28be
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SATB1 TET2 TCHHL1	9.19e-05	199	20	3	78e70852acda95d2c770cdd539a46b291f929a78
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PNISR TET2 HNRNPU	9.33e-05	200	20	3	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	LPS_only-Unknown\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TLR8 PLCE1	1.19e-03	115	20	2	7a733f6987b40ec497a03734b79ed5355ad3a2fc
ToppCell	LPS_only-Unknown-Endothelial-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TLR8 PLCE1	1.19e-03	115	20	2	c67145d3cd9243994a141749b426ff2a6dcc8d93
ToppCell	LPS_only-Unknown-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TLR8 PLCE1	1.19e-03	115	20	2	ad5298c2ad8bf94fa13c2e50b0799e929473ef59
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 EP300	1.59e-03	133	20	2	292ecfcadbaf15e0d34a3ab9bf511ab1065888bd
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 EP300	1.59e-03	133	20	2	f6e9a1301a3379847b215303a9b0c028841e2cc0
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PLCE1 PDZRN4	1.99e-03	149	20	2	98ae408d2d0347865875ff8bbd89d359decea526
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	PNISR TNRC6B	2.04e-03	151	20	2	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8\|TCGA-Thymus / Sample_Type by Project: Shred V9	PLCE1 PDZRN4	2.04e-03	151	20	2	5906562efd36fbcb91f96e0a0d3a8fe999ba1e79
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLCE1 PDZRN4	2.07e-03	152	20	2	ee329249a034a969a16b26a224aa04249d67382d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLCE1 PDZRN4	2.07e-03	152	20	2	bd1f36b436d8ab7dd8420f595b97d851eab31a38
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SATB1 UCK2	2.10e-03	153	20	2	0ad401cb70b9edfc6ae6ccba6879c6c2b6c4d296
ToppCell	PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	AR PLCE1	2.18e-03	156	20	2	605d95a900e1443d3f6aae163ef2e893d3293203
ToppCell	PND07-28-samps-Mesenchymal-Mesothelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	AR PLCE1	2.18e-03	156	20	2	574f761962a7dd3308bd41fc529dd3ea1b8625f8
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TLR8 YTHDF3	2.23e-03	158	20	2	b0508a600994090c6aafd8d779437190a33ad821
ToppCell	facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TLR8 YTHDF3	2.23e-03	158	20	2	a816cc095452308d06f87b77467e2a8c6361fd2a
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SATB1 UCK2	2.26e-03	159	20	2	a5509f0604ef0caef5ed1af83dd89c86686c73cc
ToppCell	normal_Pleural_Fluid-B_lymphocytes-Undetermined\|normal_Pleural_Fluid / Location, Cell class and cell subclass	PNISR TNRC6B	2.29e-03	160	20	2	5744cd30709f38e84f7ec8893dc19d7a288b465a
ToppCell	Entopeduncular\|World / BrainAtlas - Mouse McCarroll V32	KANK1 PLCE1	2.29e-03	160	20	2	833763c8608de4ee6003b8fb682aa9c83d7dea9b
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	PLCE1 PDZRN4	2.32e-03	161	20	2	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	PNISR TNRC6B	2.35e-03	162	20	2	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKPD1 PDZRN4	2.46e-03	166	20	2	ec7bd549bda5f18aca8aebce5ba479a81abbbeda
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KANK1 PLCE1	2.49e-03	167	20	2	351f8de1fbdf742ac74f9099b254d515ab539bb2
ToppCell	Thalamus-Macroglia-POLYDENDROCYTE\|Thalamus / BrainAtlas - Mouse McCarroll V32	HERPUD2 KANK1	2.49e-03	167	20	2	1e144c03409df94ccd39760842590e8ea7487e29
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KANK1 PLCE1	2.49e-03	167	20	2	c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2
ToppCell	CV-Mild-6\|CV / Virus stimulation, Condition and Cluster	TNRC6B KANK1	2.49e-03	167	20	2	cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SATB1 PDZRN4	2.55e-03	169	20	2	a388e53deac861a185c31e9cceddae7bcb344700
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KANK1 PLCE1	2.61e-03	171	20	2	a5634b76476b8b2488a706bbab5141f7bd94631f
ToppCell	systemic_lupus_erythematosus-treated-Hematopoietic-Progen-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SATB1 NKPD1	2.61e-03	171	20	2	61d622153b91702ef21b0efc7b9581e592b7ccea
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KANK1 PDZRN4	2.61e-03	171	20	2	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	3'_v3-lymph-node_spleen\|World / Manually curated celltypes from each tissue	PNISR TNRC6B	2.61e-03	171	20	2	7aae88da5b37c20f10118325a048f08906be994c
ToppCell	systemic_lupus_erythematosus-treated-Hematopoietic-Progen\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SATB1 NKPD1	2.61e-03	171	20	2	09b3fa120f63c411f8a0dd6bd230a9720ce83fb1
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	PLCE1 PDZRN4	2.61e-03	171	20	2	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SATB1 PDZRN4	2.64e-03	172	20	2	41ddfb316429efef5f3fa0b0621ced383d9206f0
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PNISR KANK1	2.67e-03	173	20	2	0c74bdb40e635d906fd180412c23bf7fed61621e
ToppCell	Adult-Mesenchymal-pericyte_cell-D175\|Adult / Lineage, Cell type, age group and donor	PLCE1 PDZRN4	2.67e-03	173	20	2	fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KANK1 PLCE1	2.67e-03	173	20	2	30d67738633493d47f06ae452424382f069b6c0a
ToppCell	facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 PLCE1	2.70e-03	174	20	2	197686570cec6d96a92e77e6409325d3bfe6f991
ToppCell	facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 PLCE1	2.70e-03	174	20	2	2eee7b5471672b439f95eba11494c2adf8cb7006
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KANK1 PLCE1	2.70e-03	174	20	2	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLCE1 PDZRN4	2.73e-03	175	20	2	d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLCE1 PDZRN4	2.73e-03	175	20	2	454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KANK1 PLCE1	2.73e-03	175	20	2	e78bf0c33a741bb97e987e41ac33da9e623a08ec
ToppCell	CV-Mild-6\|Mild / Virus stimulation, Condition and Cluster	TNRC6B KANK1	2.73e-03	175	20	2	c4d530dbb37942427c9cd0a1533faeb6a3a45381
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KANK1 PDZRN4	2.76e-03	176	20	2	77c3da2eaa072a6baefb5087fd07ec18c5e271cd
ToppCell	Control-Lymphoid-ILC_B\|World / Disease state, Lineage and Cell class	TNRC6B TCHHL1	2.76e-03	176	20	2	57ad9c9f5fda6bc24695587ed14190514fd8d96a
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PLCE1 PDZRN4	2.76e-03	176	20	2	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|normal_Lymph_Node / Location, Cell class and cell subclass	SEC24C UCK2	2.76e-03	176	20	2	476794ef75ce5ab732d78cfeb4944e2f841e3e92
ToppCell	B_cells-pDCs\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	UCK2 AR	2.76e-03	176	20	2	ce757de9e09a225f3f96433f103f43619b0e0dda
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLCE1 PDZRN4	2.79e-03	177	20	2	4943d040eee0f9dceaddc7498171281d170e271f
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	KANK1 HNRNPU	2.79e-03	177	20	2	eb0cfe8e9a91910f9979608ed47add48d98ce4dd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLCE1 PDZRN4	2.79e-03	177	20	2	3f2272b577c862dba8ccfb41184054bbd0ace6f5
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SATB1 UCK2	2.79e-03	177	20	2	f069197d39aacf7ad63be13133a6f3fd35d429ac
ToppCell	Control-Lymphoid-ILC_B\|Control / Disease state, Lineage and Cell class	TNRC6B TCHHL1	2.79e-03	177	20	2	3d0f4b4054185ba77071efbe53df34fee84b9b24
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	SATB1 TNRC6B	2.79e-03	177	20	2	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SATB1 TNRC6B	2.82e-03	178	20	2	73936c2e7e8855b4ab65cad425686513dba331a3
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KANK1 PLCE1	2.82e-03	178	20	2	3c973aac16988e88f5677d3d695dd772ccfd6570
ToppCell	normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	SATB1 PNISR	2.82e-03	178	20	2	fa3585383a1e7da460c88a802aaa81246d681b6b
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KANK1 PLCE1	2.82e-03	178	20	2	1e05bc26591fea16e29bcfc5f538dda1dc427f05
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EP300 HNRNPU	2.85e-03	179	20	2	fad1fbee002fcd424c03460d695559060ce41a3f
ToppCell	facs-Kidney-nan-18m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HERPUD2 SATB1	2.85e-03	179	20	2	f4fd214a9865c635d8a744ce5e0eff45174d3de4
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	PLCE1 PDZRN4	2.85e-03	179	20	2	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KANK1 PLCE1	2.85e-03	179	20	2	01302505816f272243659e20d751b61a198a2fc0
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EP300 HNRNPU	2.85e-03	179	20	2	6d4e4b64e633b2ae8514ffa1e45829d6508dac54
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PLCE1 PDZRN4	2.85e-03	179	20	2	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EP300 HNRNPU	2.85e-03	179	20	2	61a7cc01fae4115325fce0efaa5bacf8f9af5ba2
ToppCell	facs-Kidney-nan-18m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HERPUD2 SATB1	2.85e-03	179	20	2	57d8d44a793314eec8f77030f4177bfe21d41652
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UCK2 PLCE1	2.88e-03	180	20	2	da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell	facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 PLCE1	2.88e-03	180	20	2	dfb8412e1e06fa7349e66eea2ef27d9ea98b7893
ToppCell	facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 PLCE1	2.88e-03	180	20	2	0059e5acade6c895fd629767bea1c15f40b0d1b0
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SATB1 PDZRN4	2.88e-03	180	20	2	2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa
ToppCell	droplet-Heart-nan-3m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UCK2 PLCE1	2.88e-03	180	20	2	5b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UCK2 PLCE1	2.88e-03	180	20	2	50758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCell	facs-Spleen-nan-3m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB1 HNRNPU	2.88e-03	180	20	2	87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KANK1 PLCE1	2.88e-03	180	20	2	c6030e725e3d86d5d74a1676330c77ffeceb324f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SATB1 PDZRN4	2.92e-03	181	20	2	6e8c5460021d3999daec58e3d6661a6fa998fd16
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB1 KANK1	2.92e-03	181	20	2	4e81ec1580e9acb22c32c465eb46f83d1e9e424e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB1 KANK1	2.92e-03	181	20	2	ad30c01290fb98adbd0caed301a584761212c977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SATB1 KANK1	2.92e-03	181	20	2	3a3268a4dff8ffcb79e09f46490e138c96f8d916
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AR PLCE1	2.95e-03	182	20	2	f00eec1f434d92d44787d3d3343476c98c3de5b4
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	PNISR FUBP1 EP300 HNRNPU	1.97e-05	188	20	4	1421_DN
Drug	2,3,5,6-tetrachlorohydroquinone	TET2 AR	2.05e-05	8	20	2	ctd:C044578
Drug	Pirenperone [ 75444-65-4]; Up 200; 10.2uM; HL60; HT_HG-U133A	TLR8 FUBP1 HNRNPU PLCE1	2.36e-05	197	20	4	2455_UP
Drug	S 37	UCK2 AR	2.63e-05	9	20	2	CID000046875
Drug	AC1L97MU	AR HNRNPU ATN1	4.07e-05	77	20	3	CID000414413
Drug	MAR70	SATB1 AR HNRNPU	4.23e-05	78	20	3	CID000004013
Drug	R165481	AR EP300	8.73e-05	16	20	2	CID005459348
Drug	per testis	AR ATN1	1.24e-04	19	20	2	CID000006012
Drug	poly(G	NKPD1 TLR8 HNRNPU	1.31e-04	114	20	3	CID000439502
Drug	FK-156	TLR8 ATN1	2.00e-04	24	20	2	CID000122001
Drug	AC1L3V67	TLR8 EP300	2.73e-04	28	20	2	CID000147439
Drug	indirubin-3'-monoxime	SEC24C SEC24B	2.93e-04	29	20	2	CID005326739
Drug	orotidine	UCK2 ATN1	3.36e-04	31	20	2	CID000092751
Drug	17-ethynyl-5-androstene-3, 7, 17-triol	SEC24C FUBP1	3.36e-04	31	20	2	ctd:C524733
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	PNISR EP300 KANK1	4.25e-04	170	20	3	1050_DN
Drug	Fk 565	TLR8 ATN1	4.54e-04	36	20	2	CID000115204
Drug	cystamine	AR EP300 ATN1	5.10e-04	181	20	3	CID000002915
Drug	troglitazone; Down 200; 10uM; PC3; HG-U133A	SATB1 TNRC6B ATN1	6.15e-04	193	20	3	431_DN
Drug	1,2-dimethoxyethane	SEC24C SEC24B	6.18e-04	42	20	2	CID000008071
Drug	Flumequine [42835-25-6]; Down 200; 15.4uM; PC3; HT_HG-U133A	PNISR FUBP1 HNRNPU	6.24e-04	194	20	3	5104_DN
Drug	Perphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A	PNISR EP300 KANK1	6.33e-04	195	20	3	1956_DN
Drug	Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A	AR KANK1 ATN1	6.43e-04	196	20	3	6445_DN
Drug	radicicol; Down 200; 0.1uM; MCF7; HG-U133A	SEC24C PNISR EP300	6.43e-04	196	20	3	325_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A_EA	EP300 SEC24B ATN1	6.52e-04	197	20	3	994_DN
Drug	Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	TNRC6B EP300 HNRNPU	6.52e-04	197	20	3	1545_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A	FUBP1 HNRNPU ATN1	6.52e-04	197	20	3	3412_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PNISR EP300 ATN1	6.62e-04	198	20	3	3332_DN
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HG-U133A	PNISR AR ATN1	6.62e-04	198	20	3	121_DN
Drug	Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; HL60; HT_HG-U133A	FUBP1 PLCE1 ATN1	6.72e-04	199	20	3	6153_UP
Drug	flavone	AR EP300	6.78e-04	44	20	2	ctd:C043562
Drug	Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; HL60; HT_HG-U133A	PLCE1 ATN1 PDZRN4	6.82e-04	200	20	3	6123_UP
Drug	Desoxycorticosterone	AR EP300	7.74e-04	47	20	2	ctd:D003900
Disease	ascending aortic diameter	HERPUD2 TNRC6B PLCE1	1.12e-04	140	20	3	EFO_0021787
Disease	Neoplasm Recurrence, Local	TET2 AR	3.19e-04	39	20	2	C0027643
Disease	Adenocarcinoma of lung (disorder)	SATB1 UCK2 EP300	3.50e-04	206	20	3	C0152013
Disease	colonic neoplasm	TET2 TNRC6B	3.52e-04	41	20	2	EFO_0004288
Disease	primary immunodeficiency disease (is_implicated_in)	TET2 TLR8	3.70e-04	42	20	2	DOID:612 (is_implicated_in)
Disease	corpus callosum posterior volume measurement	TNRC6B PDZRN4	5.67e-04	52	20	2	EFO_0010298
Disease	aortic measurement	HERPUD2 TNRC6B PLCE1	6.23e-04	251	20	3	EFO_0020865
Disease	insulin measurement	TET2 AR KANK1	7.45e-04	267	20	3	EFO_0004467
Disease	Alcoholic Intoxication, Chronic	AR EP300 KANK1	7.53e-04	268	20	3	C0001973
Disease	esophagus squamous cell carcinoma (is_marker_for)	TET2 FUBP1	1.14e-03	74	20	2	DOID:3748 (is_marker_for)
Disease	descending aortic diameter	HERPUD2 PLCE1	1.61e-03	88	20	2	EFO_0021788
Disease	migraine disorder	KANK1 PLCE1 PDZRN4	1.72e-03	357	20	3	MONDO_0005277
Disease	Uterine leiomyoma	TNRC6B KANK1	1.72e-03	91	20	2	HP_0000131
Disease	Neurodevelopmental Disorders	TNRC6B HNRNPU	1.80e-03	93	20	2	C1535926
Disease	Squamous cell carcinoma of esophagus	EP300 PLCE1	1.88e-03	95	20	2	C0279626
Disease	birth weight	HERPUD2 TET2 PLCE1	2.36e-03	399	20	3	EFO_0004344

Protein segments in the cluster

Peptide	Gene	Start	Entry
ANHNQFQQPQGVGYP	EP300	2206	Q09472
QQQQQQQHHGNSGPP	ATN1	496	P54259
FNIIGGRPNQNNQEG	PDZRN4	236	Q6ZMN7
NGQGDQQNPAPAGQV	FUBP1	566	Q96AE4
NGHGEQQPQPPATQQ	HNRNPU	156	Q00839
NPAKHQLQNGYQGNG	KANK1	206	Q14678
QQQQQQGEDGSPQAH	AR	86	P10275
PFRQEGGHQQAPNNN	HERPUD2	321	Q9BSE4
GGHQQAPNNNAEVNN	HERPUD2	326	Q9BSE4
AGPAPHQQNGPAQNQ	SEC24B	36	O95487
HSPQQPGYQPQQNGS	SEC24C	271	P53992
QQQQQGDFGGPTPRQ	NKPD1	416	Q17RQ9
AYNGGNANPRPANNE	PLCE1	1566	Q9P212
QQGANHVNFGQQPVP	SATB1	261	Q01826
HNPNVQHQNGNPGIQ	TLR8	96	Q9NR97
QHQNGNPGIQSNGLN	TLR8	101	Q9NR97
APRNRGAGFNQNNGA	YTHDF3	356	Q7Z739
EQTLQNHQQPNGGEP	UCK2	6	Q9BZX2
IFNQNNHNFGGPPDN	PNISR	141	Q8TF01
GGHNNNPDTQRQGTP	TCHHL1	586	Q5QJ38
PHPQSNNDQQREGSF	TET2	761	Q6N021
QKGHPLPENQGNAQA	TNRC6B	541	Q9UPQ9